These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6553515)

  • 41. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
    Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
    Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of lymphokine-activated killer activity in mice by prothymosin alpha.
    Baxevanis CN; Gritzapis AD; Dedoussis GV; Papadopoulos NG; Tsolas O; Papamichail M
    Cancer Immunol Immunother; 1994 Apr; 38(4):281-6. PubMed ID: 8168124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymosin modulation of suppressor function in mice and man.
    Serrou B; Rosenfeld C; Caraux J; Thierry C; Cupissol D; Goldstein A
    Ann N Y Acad Sci; 1979; 332():95-100. PubMed ID: 161154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of thymosin and the supernatant of cultured mouse thymus reticuloepithelial cell on mouse immune responses.
    Nishida M; Miki T; Irimajiri K; Horiuchi A
    Tohoku J Exp Med; 1980 Apr; 130(4):369-80. PubMed ID: 6451053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antitumor effect of methylene blue in vivo].
    Lai BT
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):98-100. PubMed ID: 2806052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation.
    Tsukada N; Kobata T; Aizawa Y; Yagita H; Okumura K
    Blood; 1999 Apr; 93(8):2738-47. PubMed ID: 10194454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thymic factor-induced reduction of pulmonary metastases in mice with FSA-1 fibrosarcoma.
    Tomazic VJ; Sacasa CR; Loftus A; Suter CS; Elias GE
    Clin Exp Metastasis; 1988; 6(1):17-25. PubMed ID: 2961496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
    Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of antileukemic effect in combination of 5-fluorouracil and OK-432.
    Koshimura S; Ryoyama K
    Cancer Treat Rep; 1977; 61(1):17-27. PubMed ID: 324619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of helper and suppressor T cell activities by thymosin alpha 1 injection in old mice.
    Frasca D; Adorini L; Doria G
    Immunopharmacology; 1985 Aug; 10(1):41-9. PubMed ID: 2932410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of thymosin alpha1 fragments on T-lymphocyte transformation in the uremic state.
    Abiko T; Sekino H; Higuchi H
    Chem Pharm Bull (Tokyo); 1980 Nov; 28(11):3411-5. PubMed ID: 6971182
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
    Lin TS; Fischer PH; Prusoff WH
    Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
    [No Abstract]   [Full Text] [Related]  

  • 54. Elimination of EL-4 and L1210 murine tumors by 1,3-bis (2-chloroethyl)-1-nitrosourea requires an intact immune response.
    Steele TA; Cox DC
    Proc Soc Exp Biol Med; 1996 May; 212(1):63-8. PubMed ID: 8618953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapy of P388 leukemia with benzaldehyde.
    Balázová E; Koza I
    Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES; North RJ
    J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of natural killer cell activity in mice by treatment with a thymic factor.
    Bistoni F; Baccarini M; Puccetti P; Marconi P; Garaci E
    Cancer Immunol Immunother; 1984; 17(1):51-5. PubMed ID: 6563944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
    Iigo M; Nakajima Y; Kuretani K; Hoshi A
    Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
    Keizer HJ; Pauwels R; Landuyt W; Balzarini J; van der Schueren E; De Clercq E
    Cancer Lett; 1988 Mar; 39(2):217-23. PubMed ID: 3359416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice.
    Hadden JW; Saha A; Sosa M; Hadden EM
    Int J Immunopharmacol; 1995 Oct; 17(10):821-8. PubMed ID: 8707447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.